Teladoc Health Statistics

Total Valuation

Teladoc Health has a market cap or net worth of GBP 948.15 million. The enterprise value is 1.16 billion.

Market Cap	948.15M
Enterprise Value	1.16B

Important Dates

The last earnings date was Friday, April 25, 2025.

Earnings Date	Apr 25, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+3.64%
Shares Change (QoQ)	+0.74%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	161.19M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.46
PB Ratio	0.80
P/TBV Ratio	n/a
P/FCF Ratio	4.20
P/OCF Ratio	4.04
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 34.42, with an EV/FCF ratio of 5.15.

EV / Earnings	-1.45
EV / Sales	0.60
EV / EBITDA	34.42
EV / EBIT	n/a
EV / FCF	5.15

Financial Position

The company has a current ratio of 1.77, with a Debt / Equity ratio of 1.06.

Current Ratio	1.77
Quick Ratio	1.62
Debt / Equity	1.06
Debt / EBITDA	35.23
Debt / FCF	5.60
Interest Coverage	-8.77

Financial Efficiency

Return on equity (ROE) is -52.46% and return on invested capital (ROIC) is -3.73%.

Return on Equity (ROE)	-52.46%
Return on Assets (ROA)	-3.30%
Return on Invested Capital (ROIC)	-3.73%
Return on Capital Employed (ROCE)	-8.11%
Revenue Per Employee	405,632
Profits Per Employee	-158,056
Employee Count	5,500
Asset Turnover	0.65
Inventory Turnover	22.21

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.62% in the last 52 weeks. The beta is 1.10, so Teladoc Health's price volatility has been higher than the market average.

Beta (5Y)	1.10
52-Week Price Change	-47.62%
50-Day Moving Average	9.03
200-Day Moving Average	9.17
Relative Strength Index (RSI)	39.35
Average Volume (20 Days)	38,845

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.58

Income Statement

In the last 12 months, Teladoc Health had revenue of GBP 2.05 billion and -799.76 million in losses. Loss per share was -4.69.

Revenue	2.05B
Gross Profit	1.45B
Operating Income	-166.77M
Pretax Income	-793.70M
Net Income	-799.76M
EBITDA	25.34M
EBIT	-166.77M
Loss Per Share	-4.69

Full Income Statement

Balance Sheet

The company has 1.04 billion in cash and 1.27 billion in debt, giving a net cash position of -228.68 million.

Cash & Cash Equivalents	1.04B
Total Debt	1.27B
Net Cash	-228.68M
Net Cash Per Share	n/a
Equity (Book Value)	1.19B
Book Value Per Share	6.87
Working Capital	577.01M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 234.58 million and capital expenditures -8.62 million, giving a free cash flow of 225.96 million.

Operating Cash Flow	234.58M
Capital Expenditures	-8.62M
Free Cash Flow	225.96M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 70.76%, with operating and profit margins of -8.13% and -38.97%.

Gross Margin	70.76%
Operating Margin	-8.13%
Pretax Margin	-38.67%
Profit Margin	-38.97%
EBITDA Margin	1.23%
EBIT Margin	-8.13%
FCF Margin	11.01%

Dividends & Yields

Teladoc Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.64%
Shareholder Yield	-3.64%
Earnings Yield	-84.35%
FCF Yield	23.83%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Teladoc Health has an Altman Z-Score of -5.08. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.08
Piotroski F-Score	n/a